Perioperative β blockade - Authors' reply

The Lancet

Volumn 372, Issue 9644, 2008, Pages 1148-

  Fleisher, Lee A ^a   Poldermans, Don ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG MEGADOSE; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LOW DRUG DOSE; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 52949089603     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61476-2     Document Type: Letter

References (4)

1. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
2. Poldermans D. The results of the DECREASE-IV study, cardioprotective effect of bisoprolol, fluvastatin, both or control in intermediate risk patients undergoing surgery. Presented at the European Society of Anesthesiology Congress; May 31-June 3, 2008; Copenhagen, Denmark.
3. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28 (2007) 2375-2414
4. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 50 (2007) 1707-1732